Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015)

Published:2016-07-06 Issue:9 Volume:26 Page:973-977
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Zarganes-Tzitzikas Tryfon,Konstantinidou Markella,Gao Yongzhi,Krzemien Dobroslawa,Zak Krzysztof,Dubin Grzegorz,Holak Tad A.,Dömling Alexander

Funder

National Institute of Health

European Lead Factory (IMI)

ITN

Qatar National Research Foundation

National Science Centre, Poland

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/13543776.2016.1206527

Reference11 articles.

1. Programmed Death-1: Therapeutic Success after More than 100 Years of Cancer Immunotherapy

2. PD-1 and Its Ligands in Tolerance and Immunity

3. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

4. Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18

5. PD-1 Blockers

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Miniprotein engineering for inhibition of PD‐1/PD‐L1 interaction;Protein Science;2024-07-16

2. Enhancing cancer immunotherapy: Exploring strategies to target the PD-1/PD-L1 axis and analyzing the associated patent, regulatory, and clinical trial landscape;European Journal of Pharmaceutics and Biopharmaceutics;2024-07

3. Molecular glues for protein-protein interactions: Progressing toward a new dream;Cell Chemical Biology;2024-06

4. Challenges with the Synthesis of a Macrocyclic Thioether Peptide: From Milligram to Multigram Using Solid Phase Peptide Synthesis (SPPS);The Journal of Organic Chemistry;2024-04-23

5. Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges;Frontiers in Immunology;2024-04-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3